Señales en vivo de FPH.NZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 01:00):

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide...

Stats
Volumen de hoy	207 235
Volumen promedio	412 053
Capitalización de mercado	16.88B
EPS	NZD0 ( 2023-11-28 )
Próxima fecha de ganancias	( NZD0 ) 2024-05-23
Last Dividend	NZD0 ( N/A )
Next Dividend	NZD0 ( N/A )
P/E	64.22
ATR14	NZD0.0160 (0.06%)

Volumen Correlación

Largo: -0.06 (neutral)

Corto: -0.05 (neutral)

Signal:(55.174) Neutral

Fisher & Paykel Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fisher & Paykel Correlación - Moneda/Commodity

-0.76
( moderate negative )

-0.77
( moderate negative )

0.00
( neutral )

-0.84
( strong negative )

0.84
( strong )

Fisher & Paykel Finanzas

Annual	2023
Ingresos:	NZD1.59B
Beneficio Bruto:	NZD945.90M (59.54 %)
EPS:	NZD0.430

FY	2023
Ingresos:	NZD1.59B
Beneficio Bruto:	NZD945.90M (59.54 %)
EPS:	NZD0.430

FY	2022
Ingresos:	NZD1.64B
Beneficio Bruto:	NZD1.01B (61.70 %)
EPS:	NZD0.650

Financial Reports:

No articles found.

Fisher & Paykel

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.